We report the development of a competitive enzyme-linked immunosorbent assay (c-ELISA) for the detection of antibodies to porcine circovirus type 2 (PCV2), the agent associated with the recently described postweaning multisystemic wasting syndrome in pigs. At present, no method has been published describing a c-ELISA for the detection of antibodies to PCV2, and currently employed tests are impractical for use in some laboratories. The assay described here uses a cell culture isolate of porcine circovirus type 2 as antigen and a PCV2-specific monoclonal antibody as the competing reagent. Evaluation of the ELISA was performed by comparison with results obtained using an indirect immunofluorescent test on 484 sera from pig herds in the United Kingdom, Canada, France, and the USA and serial bleeds from pigs experimentally infected with porcine circoviruses. The sensitivity and specificity of the ELISA were determined as 99.58% and 97.14%, respectively, at 2 standard deviations (SD) from the mean or 95.81% and 100% at 3 SD from the mean. Using this ELISA, a serologic survey of 461 sera collected from commercial pig herds in Northern Ireland between 1973 and 1999 was undertaken. Analysis of the results of this survey demonstrated that the number of ELISA-positive sera detected in an individual year during this period ranged from 55% to 100%. This c-ELISA has applications for large-scale rapid diagnosis of PCV2 infection in pig populations worldwide and for immunoscreening of sera from other species for antibodies to PCV2.
Porcine circovirus (PCV) was first identified in 1974 as a noncytopathic contaminant of a continuous pig kidney (PK-15) cell line. 34 The virus was later shown to possess a single-stranded circular DNA genome of 1.76 kb 8, 25, 31 and is now classified in a new virus family, the Circoviridae. 23 Serum antibodies to the PCV contaminant of PK-15 cell cultures have been demonstrated in pig populations worldwide, 1, 11, 12, 18, 20, 32 However, experimental infection of pigs with this virus has failed to produce clinical disease. 4, 32 Postweaning multisystemic wasting syndrome (PMWS) in pigs, first identified in western Canada in 1991, 9 is characterized by progressive weight loss, respiratory signs, and jaundice. 9, 17 Similar syndromes have also been described in pigs in the USA, 10 France, 22 Northern Ireland, 21 Spain, 27 the Republic of Ireland, 29 Denmark, 6 and Germany. 19 The demonstration of PCV antigen and nucleic acid in lesions sug-gested that a new, more virulent PCV may have emerged in pig populations in these countries. 5, 13, 22 All PCV isolates characterized from cases of PMWS form a closely related group at the nucleotide sequence level, exhibiting Ͼ96% intragroup nucleotide sequence identity, 26 but are quite distinct from the PCV isolated from the PK-15 cell line, exhibiting less than 80% nucleotide sequence identity. 16, 24, 26 It has been proposed that the PCV associated with PMWS should be referred to as PCV type 2 (PCV2) and the PCV contaminant of PK-15 cell cultures be referred to as PCV type 1 (PCV1). 7, 26 Current testing for antibodies to PCV2 in sera is performed by indirect immunofluorescence (IIF) or indirect immunoperoxidase (IIP) staining of PCV2-infected cell cultures. 5, 14 In the hands of skilled workers such tests are very sensitive but require a level of expertise and equipment that may make the use of such tests in some laboratories problematic. These tests are also unacceptably slow when screening large numbers of sera. This report outlines the development and evaluation of a monoclonal antibody (MAb)-based, competitive enzyme-linked immunosorbent assay (c-ELISA) for detection of PCV2 antibody in pig sera, and presents the results of a small serologic survey for this antibody carried out on sera from pigs in Northern Ireland collected over the last 25 years.
Materials and methods

Cells and virus
A continuous PK-15 cell line, known to be free from PCV1, grown in minimum essential medium containing Earle's salts, 10% fetal bovine serum (FBS), and gentamycin (100 g/ml) was used for the propagation of PCV2 virus. The virus isolate used (48285) was recovered from a pig with PMWS. 5 A stock virus pool was prepared by serial passage in semiconfluent PK-15 cell cultures and glucosamine treatment as described elsewhere. 5, 33 
PCV2 antigen preparation
Virus-infected cell cultures were subjected to 3 cycles of freeze/thawing, and then sonicated in an ice bath. The resulting cell lysate (250 ml) was mixed with 0.5% Triton X-114 a and incubated at 37 C for 30 min before centrifugation at 8,000 ϫ g for 30 min. Supernatants were removed to fresh tubes and centrifuged at 70,000 ϫ g for 3 hr and the virus pellets were resuspended in 1.5 ml of TE buffer (10 mM Tris-HCl, 1 mM ethylenediametetraacetic acid, pH 8.0). Quantification of PCV2 antigen in this preparation was determined using an antigen-capture ELISA. Protein concentration was interpolated from a bovine serum albumin standard curve. b This partially purified virus was used as antigen in the c-ELISA.
Monoclonal antibodies
Antigen for mouse inoculation was prepared from PK-15 cells inoculated with PCV2, and prepared by freeze/thawing and sonication as described above. A 100-l volume of the antigen preparation was mixed with 12.5 g of purified saponin (Quil A) i and injected subcutaneously into 3 BALB/c mice. This was repeated after a 3-wk interval. One mouse was euthanized 4 days after the second immunization and the spleen was harvested. Spleen cells were fused with nonsecretory mouse myeloma cells 15, 30 and the resulting hybridoma cells were maintained on RPMI 1640 medium supplemented with 20% FBS. Supernatants from cultures of actively expanding colonies were harvested and tested (undiluted) for antibodies to PCV2 and PCV1 by IIF. 3 Colonies producing antibodies reactive to PCV2 and not to PCV1 were subcloned several times and retested. The subclone 12B6 was selected for use in the c-ELISA and high-titer MAb fluid was prepared in dialysis sacs, 28 before storing at Ϫ20 C.
Sera from experimentally infected pigs
Sera from experimentally infected pigs were used in this study. Four colostrum-deprived specific-pathogen-free piglets were inoculated intranasally with 10 5.5 median tissue culture infective doses of PCV2 virus, and 2 pigs were inoculated intranasally with a PCV1 inoculum of the same titer, derived from contaminated PK-15 cell cultures. The 2 groups of pigs were held in separate isolators and samples of blood were taken at 0, 7, 11, 15, 21, and 28 days postinoculation (DPI). Serum was separated for serological testing by ELISA and IIF.
Pig sera for c-ELISA development and retrospective serologic studies
Four hundred eighty-four serum samples collected from pigs with and without clinical signs of PMWS were collected by practitioners and organizations in the United Kingdom, Canada, France, and the USA. These samples were submitted to the Veterinary Sciences Division, Department of Agriculture for Northern Ireland, to be tested by IIF for antibodies reactive to PCV2.
Four hundred sixty-one pig sera, collected between 1973 and 1999 for disease surveillance of commercial pig herds in Northern Ireland were tested by c-ELISA for antibodies reactive to PCV2. Eighty-five of these serum samples were also tested by IIF.
Optimization of c-ELISA
Optimum dilutions of PCV2 coating antigen, PCV2-specific MAb, and horseradish peroxidase-conjugated goat antimouse immunoglobulin G (IgG) c (HRP-GAM) were established by systematic checkerboard titrations. The test serum dilution of 1:125 was determined by comparing end-point titrations of positive experimental and field sera by c-ELISA and IIF. Conjugate test wells and conjugate background wells were systematically placed in 2 different areas of each plate to compensate for edge and center effects. Pre-and postinoculation sera from a PCV2-infected experimental pig were used as negative and positive controls throughout the assay, providing defined percentage inhibitions (PIs) for quality control.
Serologic studies
Indirect immunofluorescence. Pig sera were tested by IIF according to protocols described previously. 3 Briefly, pig sera were diluted 1:50 and 1:250 in phosphate-buffered saline (PBS) and applied to acetone-fixed PCV2-infected PK-15 cell culture coverslip preparations. Known positive and negative pig sera and a no-serum conjugate control were used throughout the IIF testing. After incubation at 37 C for 1 hr, coverslips were washed in PBS, and a fluoroscein-isothiocyanate-conjugated rabbit anti-swine IgG d was applied for 1 hr at 37 C. The preparations were washed in PBS, and mounted in buffered glycerol saline before viewing under incident UV illumination. Sera were considered positive when intensely fluorescent staining cells were observed.
Competitive ELISA. The c-ELISA was performed in microtiter plates e and comprised 4 successive addition and incubation steps before reaction with enzyme substrate. With the exception of the second step, 4 thorough washing cycles were carried out manually after each step, using PBS containing 0.05% Tween 20 f (PBS-T).
Plates were coated overnight at 4 C with 100 l of PCV2 antigen at 0.85 g/ml diluted in 0.05 M carbonate-bicarbonate buffer (pH 9.6). Pig sera were diluted 1:125 in PBS-T and 50 l was added to duplicate serum test wells and duplicate serum background wells and incubated at 37 C for 45 min. Phosphate-buffered saline containing Tween 20 was added to 4 conjugate test wells and 4 conjugate background wells. Without the removal of sera, test wells received 50 l of PCV2-specific MAb, 12B6, diluted to 42 g/ml in PBS- T, whereas the background wells received PBS-T only, followed by an incubation period of 30 min at 37 C. Conjugated HRP-GAM, diluted 1:8,000 in PBS-T containing 5% normal goat serum, was added in 100-l volumes to all wells and incubated for 1 hr at 37 C. The enzyme substrate 3,3-,5,5tetramethylbenzidine g was added at room temperature and the reaction was stopped after 10 min with 1 M H 2 SO 4 . Absorbency was read at 450 nm. h The optical density (OD) results were interpreted by calculating the PI using the following formula:
where serum OD (for each serum) ϭ mean serum test wells Ϫ mean serum background wells and control OD ϭ mean conjugate test wells Ϫ mean conjugate background wells (ϭ0% inhibition).
The cut-off between positive and negative sera was calculated from the mean percentage inhibition of the IIF-negative sera plus 2 or 3 standard deviations (SD) of the mean. 35 This calculation gives 95% or 99% confidence that all negative values will fall within the defined range.
The sensitivity and specificity of the ELISA were calculated by the following formulae: Interassay variation for the c-ELISA was evaluated by the retesting 3 times of 24 sera, with PIs between 24% and 100%.
Results
Monoclonal antibodies. Initially, 6 clones were selected by IIF for their ability to exhibit specific staining of PCV2-infected cell cultures and nonreactivity with PCV1-infected cell cultures. Monoclonal antibody 12B6 was chosen for use in the c-ELISA because it exhibited the highest antibody titer against PCV2 of the 6 clones tested.
Sera from experimentally infected piglets. Sera from 2 groups of piglets, 1 group experimentally infected with PCV1 and the other with PCV2, were tested by IIF and c-ELISA for antibodies to PCV2. All serum samples from pigs inoculated with PCV1 were nonreactive when tested by IIF on PCV2-infected cell cultures and exhibited OD values Ͼ 0.91 when assayed on the PCV2-specific c-ELISA (Ͻ17% inhibition). Serum from these pigs sampled at 11, 15, and 28 DPI was reactive when tested by IIF against PCV1-infected cell cultures. Serum samples from pigs inoculated with PCV2 sampled at 0 and 7 DPI and 2 pigs sampled at 11 DPI were nonreactive when tested by IIF on PCV2infected cell cultures. These sera had OD values in excess of 0.85 when tested on the PCV2-specific c-ELISA (Ͻ30% inhibition). Serum samples from 2 of the PCV2-inoculated pigs sampled at 11 DPI and serum samples from the pigs in this group taken at 15, 21, and 28 DPI were reactive when tested by IIF on PCV2-infected cell cultures. These sera had OD values Ͻ0.69 when assayed on the PCV2-specific c-ELISA (Ͼ45% inhibition). These sera were the only samples from the experimentally infected pigs deemed to contain antibody to PCV2.
Serologic studies. All 484 field sera collected for c-ELISA evaluation studies were tested by IIF and c-ELISA. Distribution of the c-ELISA PI values showing the frequency of IIF-positive and -negative sera are presented in Fig. 1 . The cutoffs used to discriminate between positive and negative samples were derived from the mean PI of the IIF-negative sera (10.76%) plus 2 SD, or from the mean plus 3 SD, giving 95% or 99% confidence, respectively, that all negative pig sera will fall within the defined range (1 SD ϭ 11.07%). Using the former level, the cutoff was 33% inhibition, giving a specificity of 97.14% and a sensitivity of 99.58%. If the positivity threshold was increased to the mean plus 3 SD, cutoff increased to 44% inhibition, giving a specificity of 100% and a sensitivity of 95.81% ( Table 1) .
Reproducibility of the ELISA was calculated from the interassay variation of results. The range of means and SD of 3 separate assays testing the same 24 sera are shown in Table 2 . Of the 24 sera tested only 2 samples had SD values greater than 3.61%, and of the 14 sera in the 91-100 mean PI range, just 1 serum had an SD value over 1.73%.
The results of c-ELISA testing of pig sera for antibodies to PCV2 in the retrospective study are presented in Table 3 . PCV2 antibody was detected in the majority of the pig serum samples tested from 1973 until 1999. The percentage of sera containing antibody to PCV2 showed a marked increase in the samples collected in 1988 (100%) and 1999 (92.1%) when compared to those collected in earlier years (1973, ). This increase in the percentage of PCV2-positive sera was also reflected in the number of PCV2 seropositive herds.
Discussion
Postweaning multi systemic wasting syndrome in pigs is a newly emerging and potentially devastating wasting disease of weaned piglets. Although not yet confirmed as the single causal agent of the disease, PCV2 antigen has been consistently demonstrated in close association with lesions in pigs with PMWS, 5, 6, 13, 14 and the disease has been reproduced experimentally after inoculation of 1-day-old piglets with PCV2. 2 Isolates of PCV2 have been made from pigs with wasting disease in Canada, 13 the USA, 5 and various countries in Europe. 5, 6, 19 To date, little information on the extent of antibodies to PCV2 in pigs is available and no rapid, PCV2-specific immunologic assays have been reported or are commercially available. PCV2 antibodies are currently detected using IIF or IIP assays on PCV2-infected cell cultures. However, because of a slight antigenic cross-reactivity between PCV2 and PCV1, 5 these tests are not PCV2-specific when carried out on a single dilution. This communication describes the development and application of a c-ELISA for the detection of PCV2 serum antibody in pigs, and other species, that employs a PCV2-specific MAb as a competitor with test sera for binding sites on a partially purified PCV2 antigen. The MAb used in this assay (12B6) was chosen because of its absence of reactivity to PCV1 viruses and its reactivity to high titer with all PCV2 isolates from pigs with PMWS currently held in our laboratory (data not shown). Indeed, this MAb also reacted to high titer with PCV2 isolates recently recovered from reproductive disorders in pigs in Canada. 36 Field sera for c-ELISA evaluation and sera from pigs experimentally infected with PCV1 or PCV2 were tested by IIF at 2 dilutions (1:50 and 1:250) to negate cross-reactivity, which may have occurred between PCV2-infected cell cultures and PCV1 antibody in pig sera. No cross-reactivity between these 2 viruses was detected in the sera from experimentally infected pigs. Although cross-reactivity has been demonstrated by IIF using hyperimmune rabbit antibodies to PCV1 virus, 5 the extent to which cross-reactivity occurs in pig sera is very limited and can be controlled by testing sera at relatively high dilution.
The sensitivity and specificity of the PCV2-specific c-ELISA developed here was determined by comparison of results using IIF on 484 field sera from pigs. A cutoff value of 33% inhibition optimizes the specificity and sensitivity balance of the c-ELISA. Using this cutoff value, 1 IIF-positive/c-ELISA-negative serum with a PI value of 31 was detected. This serum possibly contained antibodies to a different ''strain'' of PCV2 that were reactive by IIF, a test that detects antibody to a wide range of viral epitopes, but not by the c-ELISA, which is designed to specifically detect antibodies that are competing with an MAb reactive against a single epitope of PCV2. Alternatively, this serum could have contained a specific porcine immunoglobulin subtype not reactive in the ELISA, but detected in an IIF test that uses a whole anti-swine immunoglobulin. At the 33% cutoff value, 7 IIF-negative/c-ELISA-positive sera were detected when compared with IIF. The c-ELISA developed here is a potentially more sensitive test than IIF; however, the PI values of these 7 sera recorded on the c-ELISA (33, 35, 35, 36, 37 , 37, 39) could also be explained by nonspecific competition with the MAb for binding sites. The nature of this nonspecific competition is currently being investigated. Using a cutoff value of 44%, no IIF-negative/c-ELISA-positive sera were found. However, the number of IIF-positive/c-ELISA-negative sera increased to 10 and consequently the sensitivity of the assay was reduced. The designation of a gray zone in the region 33% to 44% inhibition is proposed, and all sera falling within this area should be subject to a retest. Of the 484 sera used in the evaluation of this assay, 16 fall within this region, representing only 3.3% of the total number tested.
Although all cases of PMWS reported to date have been shown to be strongly associated with PCV2 infection, 5, 6, 13 and experimental reproduction of disease in pigs with PCV2 has been achieved, 2 the presence of antibodies reactive to PCV2 in pigs, with and without clinical signs of PMWS, tested during this study indicates that infection of pigs with a PCV2 virus does not necessarily result in disease. Indeed, the presence of PCV2-specific antibody in pigs as early as 1973, more than 20 years before the first report of PMWS in pigs, 21 strongly supports this argument. New, more virulent, strains of PCV2 possibly have emerged in the 1990s or some other external factor such as environmental or husbandry changes may have occurred that have influenced the clinical outcome of PCV2 infection. Synergistic enhancement of clinical disease after coinfection of pigs with other agents such as porcine parvovirus (PPV) or porcine respiratory and reproductive syndrome virus cannot be discounted; indeed, recent studies 2 have produced severe clinical disease and PMWS-like lesions in pigs coinfected with PCV2 and PPV.
The purpose of this study was to develop a competitive ELISA for detection of antibodies specific for PCV2 and evaluate its performance compared to IIF. The results demonstrate that the 2 tests correlate well with relative sensitivity and specificity of 99.58% and 97.14%, respectively, at the 33% cutoff level. This c-ELISA has been demonstrated to be a useful test for the detection of antibodies to PCV2, and to be highly sensitive, specific, and suitable for screening large numbers of sera. In the event of future widespread vaccination for PCV2 infection, the c-ELISA could also be a useful tool for monitoring seroconversion in vaccinated pigs.
